The Dominance of Global Pharmaceutical Giants and the Role of Biotech Startups The competitive landscape of the Parkinson's disease therapeutics market is a dynamic ecosystem featuring large, established pharmaceutical companies that manage the existing drug portfolio (e.g., Levodopa formulations) and numerous small, agile biotech firms focused on novel, high-risk disease-modifying targets....